Autoimmune Diseases
Welcome,         Profile    Billing    Logout  
 293 Companies   490 Products   490 Products   199 Mechanisms of Action   25 Trials   7787 News 


«12...8889909192939495969798...156157»
  • ||||||||||  Plegridy (PEG-interferon β-1a) / Biogen
    Enrollment closed:  Long-Term Safety and Efficacy Study of Peginterferon Beta-1a (clinicaltrials.gov) -  Jul 30, 2014   
    P3,  N=1500, Active, not recruiting, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2014 --> Sep 2014 Enrolling by invitation --> Active, not recruiting
  • ||||||||||  Enrollment closed, Trial primary completion date:  Accu-Chek Combo in Young Patients (clinicaltrials.gov) -  Jul 30, 2014   
    P=N/A,  N=15, Active, not recruiting, 
    Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2013 --> Dec 2014
  • ||||||||||  Trial completion, Enrollment change, Trial initiation date, Trial primary completion date, HEOR:  HORA: Health Outcomes in Rheumatoid Arthritis in Greece (clinicaltrials.gov) -  Jul 28, 2014   
    P=N/A,  N=210, Completed, 
    Trial primary completion date: Mar 2016 --> Nov 2012 Active, not recruiting --> Completed | N=460 --> 210 | Initiation date: Jan 2010 --> Jul 2010 | Trial primary completion date: Nov 2013 --> Jun 2012
  • ||||||||||  Uplizna (inebilizumab) / Horizon Therapeutics, Mitsubishi Tanabe
    Enrollment closed, Trial primary completion date:  Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple Sclerosis (clinicaltrials.gov) -  Jul 28, 2014   
    P1,  N=28, Active, not recruiting, 
    Active, not recruiting --> Completed | N=460 --> 210 | Initiation date: Jan 2010 --> Jul 2010 | Trial primary completion date: Nov 2013 --> Jun 2012 Recruiting --> Active, not recruiting | Trial primary completion date: Oct 2014 --> Feb 2015
  • ||||||||||  pepinemab (VX15) / Vaccinex
    Enrollment closed, Trial primary completion date:  Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS (clinicaltrials.gov) -  Jul 27, 2014   
    P1,  N=50, Active, not recruiting, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Oct 2014 --> Feb 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2015 --> Jun 2015
  • ||||||||||  Benlysta (belimumab) / GSK
    Enrollment change, Trial withdrawal, Trial primary completion date:  A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia. (clinicaltrials.gov) -  Jul 24, 2014   
    P2,  N=0, Withdrawn, 
    Initiation date: Dec 2012 --> Mar 2013 N=48 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jul 2013 --> Apr 2015
  • ||||||||||  Orencia (abatacept) / BMS
    Enrollment closed:  ACTION: Long Term Experience With Abatacept in Routine Clinical Practice (clinicaltrials.gov) -  Jul 24, 2014   
    P=N/A,  N=1255, Active, not recruiting, 
    N=48 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jul 2013 --> Apr 2015 Recruiting --> Active, not recruiting
  • ||||||||||  Enbrel (etanercept) / Pfizer, Amgen
    Enrollment open:  Etanercept in Rheumatoid Arthritis and Vascular Inflammation (clinicaltrials.gov) -  Jul 24, 2014   
    P4,  N=10, Recruiting, 
    Trial primary completion date: Jun 2014 --> Dec 2014 Not yet recruiting --> Recruiting
  • ||||||||||  Actemra IV (tocilizumab) / Roche, JW Pharma
    Trial primary completion date:  Tocilizumab Treatment in Graves (clinicaltrials.gov) -  Jul 23, 2014   
    P3,  N=32, Recruiting, 
    Trial primary completion date: Apr 2014 --> Dec 2014 Trial primary completion date: Dec 2013 --> Jun 2015
  • ||||||||||  Enrollment open, Trial initiation date, Trial primary completion date:  SIAMMS-II: Repeat Infusion of Autologous Bone Marrow Cells in Multiple Sclerosis (clinicaltrials.gov) -  Jul 21, 2014   
    P1,  N=6, Recruiting, 
    Recruiting --> Completed | Trial primary completion date: May 2015 --> Jul 2014 Not yet recruiting --> Recruiting | Initiation date: Oct 2013 --> Jan 2014 | Trial primary completion date: Sep 2015 --> Sep 2016
  • ||||||||||  Trial completion, Enrollment change:  A Pilot Study of Moderate Hyperbilirubinemia in Type 1 Diabetes Mellitus (clinicaltrials.gov) -  Jul 21, 2014   
    P1,  N=15, Completed, 
    N=94 --> 64 | Recruiting --> Terminated; Following the emergence of an unexpected pharmacodynamic effect, the sponsor has decided to conclude the study early without fully achieving its objective Recruiting --> Completed | N=40 --> 15
  • ||||||||||  Trial primary completion date:  Evaluation of Coagulation in Multiple Sclerosis (clinicaltrials.gov) -  Jul 18, 2014   
    P=N/A,  N=100, Recruiting, 
    Recruiting --> Completed | N=40 --> 15 Trial primary completion date: Jun 2013 --> Apr 2015